Loading...
XSTO
SERT
Market cap16mUSD
Jul 11, Last price  
0.62SEK
1D
-3.89%
1Q
-25.00%
Jan 2017
-87.86%
IPO
-75.00%
Name

Serstech AB

Chart & Performance

D1W1MN
P/E
—
P/S
3.01
EPS
—
Div Yield, %
—
Shrs. gr., 5y
20.24%
Rev. gr., 5y
22.76%
Revenues
52m
-16.93%
911,497491,1181,131,8902,700,97817,496,22116,805,68110,588,10118,742,15320,488,00018,651,00017,112,00062,913,00052,262,000
Net income
-9m
L
-839,375-3,543,243-8,402,447-8,116,858-6,417,469-2,547,047-12,330,561-15,877,170-6,730,000-10,252,000-29,566,000715,000-9,131,000
CFO
562k
-92.64%
-1,866,43300005,893,000-11,823,000-10,586,0003,558,000-628,000-13,158,0007,631,000562,000

Profile

Serstech AB provides chemical identification instruments worldwide. It offers the Serstech 100 Indicator, a handheld, small, and light Raman spectrometer for measuring chemicals, such as explosives, narcotics, toxic industrial chemicals, pharmaceuticals, and chemical warfare agents; and ChemDash, a central management software for Serstech devices. The company also provides Serstech Arx and Serstech Arx+ revolutionizing instruments for quick and precise identification of chemical substances; and Serstech's SERS kit that allows for quick identification of low concentrations and narcotics samples. It offers its solutions for explosive, CBRN and hazmat, narcotics, and pharma applications. Serstech AB was incorporated in 2006 and is headquartered in Lund, Sweden.
URL
https://serstech.com/
IPO date
Aug 29, 2013
Employees
20
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
52,262
-16.93%
62,913
267.65%
17,112
-8.25%
Cost of revenue
13,936
14,320
28,670
Unusual Expense (Income)
NOPBT
38,326
48,593
(11,558)
NOPBT Margin
73.33%
77.24%
Operating Taxes
41
37
80
Tax Rate
0.11%
0.08%
NOPAT
38,285
48,556
(11,638)
Net income
(9,131)
-1,377.06%
715
-102.42%
(29,566)
188.39%
Dividends
Dividend yield
Proceeds from repurchase of equity
20,917
BB yield
-25.33%
Debt
Debt current
1,800
739
Long-term debt
4,000
Deferred revenue
Other long-term liabilities
967
802
216
Net debt
(9,288)
(16,672)
182
Cash flow
Cash from operating activities
562
7,631
(13,158)
CAPEX
(745)
(318)
(7,590)
Cash from investing activities
(7,946)
(9,003)
(7,590)
Cash from financing activities
(1,800)
17,978
3,040
FCF
2,775
44,783
(8,453)
Balance
Cash
9,288
18,472
1,866
Long term investments
2,691
Excess cash
6,675
15,326
3,701
Stockholders' equity
(72,605)
(87,255)
Invested Capital
77,523
123,179
118,631
ROIC
38.15%
40.16%
ROCE
49.44%
96.08%
EV
Common stock shares outstanding
207,573
145,918
83,816
Price
1.28
126.15%
0.57
102.14%
0.28
-80.00%
Market cap
265,694
221.70%
82,590
251.92%
23,469
-81.95%
EV
256,406
65,918
23,707
EBITDA
38,326
60,538
(3,525)
EV/EBITDA
6.69
1.09
Interest
284
209
Interest/NOPBT
0.58%